Muscle News and Research

RSS

Viewpoints: Rove offers strategy to fight Democrats' 'Mediscare' tactics; GOP offers no 'pragmatic alternative' to health law

The midterm election is still 19 months away, but for some it's never too early for demagoguery. And so this week the Democratic Congressional Campaign Committee launched a new "Mediscare" ad.

5 Apr 2013

Weight loss and heart damage: an interview with Dr Lili Barouch, Johns Hopkins University School of Medicine

Obesity causes an increase in the stiffness of the heart, making it hard for the heart muscle to relax and fill with blood in between heartbeats. This abnormal stiffness can lead to congestive heart failure and other problems as it becomes more severe.

4 Apr 2013

Anthem Life Insurance supports Warfighter Sports program for fourth consecutive year

For the fourth year in a row, Anthem Life Insurance Company supports Disabled Sports USA's Warfighter Sports program to help severely injured service men and women rebuild their lives through sports with a ski event in the Tahoe ski area in Olympic Valley, California, from April 4 through April 6.

4 Apr 2013

New tool can help improve ultrasound treatment for soft tissue injuries

A new tool developed at the National Physical Laboratory (NPL), the UK's National Measurement Institute, could help improve the quality of ultrasound treatment for soft tissue injuries such as muscle strains and ligament damage.

4 Apr 2013

Research findings shed light on how neurons translate sensory input into actions

New research by scientists at the University of Massachusetts Medical School shows at the single cell level how an external stimulus sets off a molecular chain reaction in the transparent roundworm C. elegans, a process in which a single neurotransmitter coordinates and times two separate actions.

3 Apr 2013

Engineers develop prototype telerobotic platform for bladder cancer treatment

Although bladder cancer is the sixth most common form of cancer in the U.S. and the most expensive to treat, the basic method that doctors use to treat it hasn't changed much in more than 70 years.

3 Apr 2013

Revance Therapeutics raises $33M in Series E financing

Revance Therapeutics, Inc., a privately held specialty biopharmaceutical company developing novel botulinum toxin products for use in aesthetic and therapeutic indications, today announced that it has raised $33 million of its Series E growth financing.

2 Apr 2013

N30 Pharmaceuticals presents preclinical data of GSNORi at European Cystic Fibrosis Society meeting

N30 Pharmaceuticals, Inc., a clinical stage, biopharmaceutical company focused on the development of therapies for cystic fibrosis, announced today the presentation of key preclinical data for its novel inhibitors of S-nitrosoglutathione reductase.

2 Apr 2013

Modifiable lifestyle factors may prevent progression of Barrett's-related esophageal cancer

An estimated 20 million Americans have chronic heartburn. About 2 million of these people have Barrett's esophagus, a precancerous condition that affects the tube that carries food from the mouth to the stomach.

2 Apr 2013

Johns Hopkins scientists identify role of central nervous system cell in development of ALS

Johns Hopkins scientists say they have evidence from animal studies that a type of central nervous system cell other than motor neurons plays a fundamental role in the development of amyotrophic lateral sclerosis, a fatal degenerative disease.

1 Apr 2013

State roundup: NYC firms will be required to offer sick leave; Fla. government part-timers to get health coverage

New York is poised to mandate that companies with 15 or more employees provide paid time off for them when they are sick. A compromise agreement reached Thursday night resulted from a raw display of political muscle by a coalition of labor unions and liberal activists who overcame fierce objections from New York's business-minded mayor, Michael R. Bloomberg, and his allies in the corporate world (Barbaro and Grynbaum, 3/28).

30 Mar 2013

First Edition: March 29, 2013

Today's early morning highlights from the major news organizations, including coverage of renewed interest between President Barack Obama and congressional Republicans to find ways to cut Medicare costs:

29 Mar 2013

Adding muscle to plans' push for value-based health care

A survey from Catalyst for Payment Reform, a nonprofit lobbying group comprising highly profitable Fortune 500 giants, found that many of its members do not feel like they are getting the value for which they are paying.

29 Mar 2013

KineMed renews research collaboration with Pfizer for advancement of novel diabetes pathways

KineMed Inc. today announced the renewal of a non-exclusive research collaboration with Pfizer Inc. for the advancement of novel approaches towards metabolic disease, in particular Type II Diabetes.

From Pfizer, Inc. 28 Mar 2013

Exosomes can transfer membrane proteins, study reveals

Important new research from UMass Medical School demonstrates how exosomes shuttle proteins from neurons to muscle cells where they take part in critical signaling mechanisms, an exciting discovery that means these tiny vehicles could one day be loaded with therapeutic agents, such as RNA interference, and directly target disease-carrying cells.

28 Mar 2013

Tecfidera gets FDA approval for adults with relapsing forms of MS

The U.S. Food and Drug Administration today approved Tecfidera (dimethyl fumarate) capsules to treat adults with relapsing forms of multiple sclerosis.

28 Mar 2013

Study: Gene therapy can boost heart muscle function

In an animal study, researchers at the University of Washington show that it is possible to use gene therapy to boost heart muscle function. The finding suggests that it might be possible to use this approach to treat patients whose hearts have been weakened by heart attacks and other heart conditions.

27 Mar 2013

Study provides important insight into how BMT treatment works in patients with MS

A new study by Multiple Sclerosis researchers at three leading Canadian centres addresses why bone marrow transplantation has positive results in patients with particularly aggressive forms of MS.

27 Mar 2013

Bladder cancer risk linked to genetic alterations

A new analysis has found that genetic alterations in a particular cellular pathway are linked with bladder cancer risk, recurrence, disease progression, and patient survival. Published early online in CANCER, a peer- reviewed journal of the American Cancer Society, the findings could help improve bladder cancer screening and treatment.

26 Mar 2013

Gladstone investigator to receive Essey Award for fight against amyotrophic lateral sclerosis

Shinya Yamanaka, MD, PhD, a senior investigator at the Gladstone Institutes, next month will receive the Essey Award for his "Commitment to a Cure" from The ALS Association Golden West Chapter.

26 Mar 2013

Muscle News and Research

Viewpoints: Rove offers strategy to fight Democrats' 'Mediscare' tactics; GOP offers no 'pragmatic alternative' to health law

Weight loss and heart damage: an interview with Dr Lili Barouch, Johns Hopkins University School of Medicine

Anthem Life Insurance supports Warfighter Sports program for fourth consecutive year

New tool can help improve ultrasound treatment for soft tissue injuries

Research findings shed light on how neurons translate sensory input into actions

Engineers develop prototype telerobotic platform for bladder cancer treatment

Revance Therapeutics raises $33M in Series E financing

N30 Pharmaceuticals presents preclinical data of GSNORi at European Cystic Fibrosis Society meeting

Modifiable lifestyle factors may prevent progression of Barrett's-related esophageal cancer

Johns Hopkins scientists identify role of central nervous system cell in development of ALS

State roundup: NYC firms will be required to offer sick leave; Fla. government part-timers to get health coverage

First Edition: March 29, 2013

Adding muscle to plans' push for value-based health care

KineMed renews research collaboration with Pfizer for advancement of novel diabetes pathways

Exosomes can transfer membrane proteins, study reveals

Tecfidera gets FDA approval for adults with relapsing forms of MS

Study: Gene therapy can boost heart muscle function

Study provides important insight into how BMT treatment works in patients with MS

Bladder cancer risk linked to genetic alterations

Gladstone investigator to receive Essey Award for fight against amyotrophic lateral sclerosis

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News